Literature DB >> 11345721

alpha-Phenyl-tert-N-butyl nitrone (PBN) improves functional and morphological outcome after cortical contusion injury in the rat.

N Marklund1, F Clausen, A Lewén, D A Hovda, Y Olsson, L Hillered.   

Abstract

alpha-Phenyl-tert-N-butyl nitrone (PBN), a potent reactive oxygen species (ROS) scavenger, has shown robust neuroprotective properties in several models of acute brain injury, although not previously evaluated in traumatic brain injury (TBI). In this study, we assessed the potential efficacy of PBN in a weight drop model producing a controlled cortical contusion. Sham operation, mild or severe injury was induced in intubated and ventilated rats and functional and morphological outcome was used as end-points at two weeks post-injury. In the trauma groups, saline or PBN (30 mg/kg) was injected as an intravenous bolus 30 minutes prior to injury. At day 11-15 post-injury, cognitive disturbance was assessed using the Morris Water Maze (MWM) and estimation of lesion volume and hemispheric loss of tissue was made. No change in MWM performance were found in either of the mildly traumatized groups as compared to uninjured controls. In contrast, a significant decrease in total mean latency and increase in path length in the severely traumatized rats were found. PBN-treatment significantly improved MWM performance as compared to saline treatment at the severe injury level (p < 0.05). The mild injury level caused a discrete atrophy of the ipsilateral cortex with no effect of PBN treatment. The severe injury caused a substantial loss of ipsilateral hemispheric tissue and a large cortical cavitation. PBN pre-treatment significantly reduced the lesion volume and reduced hemispheric loss of tissue at this injury level (p < 0.05). Our results support the involvement of ROS in the injury process contributing to the tissue loss and cognitive disturbance after TBI. The potential clinical utility of PBN will have to be assessed using a post-injury dosing regime.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11345721     DOI: 10.1007/s007010170141

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  9 in total

1.  In silico investigation of intracranial blast mitigation with relevance to military traumatic brain injury.

Authors:  Michelle K Nyein; Amanda M Jason; Li Yu; Claudio M Pita; John D Joannopoulos; David F Moore; Raul A Radovitzky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 2.  Nitrones as therapeutics.

Authors:  Robert A Floyd; Richard D Kopke; Chul-Hee Choi; Steven B Foster; Sabrina Doblas; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2008-08-29       Impact factor: 7.376

Review 3.  Antioxidant therapies for traumatic brain injury.

Authors:  Edward D Hall; Radhika A Vaishnav; Ayman G Mustafa
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

Review 4.  Antioxidant therapies in traumatic brain and spinal cord injury.

Authors:  Mona Bains; Edward D Hall
Journal:  Biochim Biophys Acta       Date:  2011-11-04

5.  Energy metabolic changes in the early post-injury period following traumatic brain injury in rats.

Authors:  Niklas Marklund; Konstantin Salci; Gunnar Ronquist; Lars Hillered
Journal:  Neurochem Res       Date:  2006-08-15       Impact factor: 3.996

6.  Increased expression of ferritin in cerebral cortex after human traumatic brain injury.

Authors:  Huan-Dong Liu; Wei Li; Zhen-Rui Chen; Meng-Liang Zhou; Zong Zhuang; Ding-Ding Zhang; Lin Zhu; Chun-Hua Hang
Journal:  Neurol Sci       Date:  2012-10-19       Impact factor: 3.307

7.  Superoxide Dismutase-Loaded Porous Polymersomes as Highly Efficient Antioxidants for Treating Neuropathic Pain.

Authors:  Sonia Kartha; Lesan Yan; Christine L Weisshaar; Meagan E Ita; Vladimir V Shuvaev; Vladimir R Muzykantov; Andrew Tsourkas; Beth A Winkelstein; Zhiliang Cheng
Journal:  Adv Healthc Mater       Date:  2017-07-03       Impact factor: 9.933

8.  In Vitro and In Vivo Pipeline for Validation of Disease-Modifying Effects of Systems Biology-Derived Network Treatments for Traumatic Brain Injury-Lessons Learned.

Authors:  Anssi Lipponen; Teemu Natunen; Mika Hujo; Robert Ciszek; Elina Hämäläinen; Jussi Tohka; Mikko Hiltunen; Jussi Paananen; David Poulsen; Emilia Kansanen; Xavier Ekolle Ndode-Ekane; Anna-Liisa Levonen; Asla Pitkänen
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

Review 9.  Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions.

Authors:  Abbas Jarrahi; Molly Braun; Meenakshi Ahluwalia; Rohan V Gupta; Michael Wilson; Stephanie Munie; Pankaj Ahluwalia; John R Vender; Fernando L Vale; Krishnan M Dhandapani; Kumar Vaibhav
Journal:  Biomedicines       Date:  2020-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.